RE:RE:RE:RE:RE:January 2019 investor presentationI raised the issue of the positive control in NA trial loong ago and Wex said company confirmed this in his personal communication. However this issue is not mentioned anywhere explicitly. I wonder instead of saying the same thing in the video as in the update why Howard did not give real details. If there is positive control say it, if you already have preclinical efficiency data (not enzyme binding binding or toxicity) superior to marketed product, say it.
Double blind does not mean positive control is included. If not, then they can release a final update: 1067 showed a skin lightenening effect. Is it good enough? No way to comment on this without a comparison with one of the marketed products (unless 1067 makes you like albino, then you do not need such postive control).
Chinese are doing this test which is good but I find it strange that in NA it is not confirmed officially.